Colin H. Chalk, MD, CM, FRCPC - Neurology

Dr. Colin Chalk is currently an associate professor with the Department of Neurology and Neurosurgery at McGill University in Montreal. In addition, Dr. Chalk serves on the faculty of McGill University as an associate member of the Department of Anatomy and Cell Biology and is an associate physician in neurological medicine at Montreal General Hospital. Dr. Chalk has focused much of his study on significant nerve disorders such as peripheral neuropathy, Guillain-Barré syndrome, and demyelinating diseases.

Dr. Chalk began his career at the Mayo Clinic, where he completed his residency in neurology in 1990 and earned the Henry W. Woltman award for superior performance in clinical neurology. Since then, McGill University has named him Teacher of the Year three times and added him to the Faculty Honor List for Educational Excellence.

Dr. Chalk has been on the editorial board for Seminars in Neurology and is an ad hoc reviewer for numerous medical and scientific journals, such as Neurology and the Canadian Journal of Neurological Science.

Fellow, Royal College of Physicians of Canada (Neurology)—1990.

Bell's Palsy

Benign Paroxysmal Positional Vertigo (BPPV)

Nervous System Problems

Seizures

Vestibular Neuronitis

Epilepsy

Alzheimer's Disease

Stroke

Dementia

MD: McGill University, Montreal, QC, 1984

Internship: St. Paul's Hospital, Vancouver, BC, 1984–1985

Residency in Internal Medicine: St. Paul's Hospital, University of British Columbia, Vancouver, BC, 1985–1986

Residency in Neurology: Mayo Clinic, Rochester, MN, 1986–1988

Senior Registrar and Clinical Lecturer in Neurology: Radcliff Infirmary (University of Oxford), Oxford, UK, 1988–1989

Resident in Neurology: Mayo Clinic, Rochester, MN, 1989–1990

Fellowship in Peripheral Nerve Diseases: Mayo Clinic, Rochester, MN, 1990–1991

Associate Professor, Department of Neurology and Neurosurgery, Faculty of Medicine, McGill University, Montreal, QC

Associate Member, Department of Anatomy and Cell Biology, Faculty of Medicine, McGill University, QC

Associate Physician, Department of Medicine (Neurology), Montreal General Hospital, Montreal, QC

1. Suarez GA, Chalk CH, et al. (2001). Diagnostic accuracy and certainty from sequential evaluations in peripheral neuropathy. Neurology, 57: 1118–1120.
2. Apfel SC, Asbury AK, Bril V, Burns TM, Campbell JN, Chalk CH, et al. (2001). Positive neuropathic sensory symptoms as endpoints in diabetic neuropathy trials. Journal of Neurological Science, 189: 3–5.
3. Ashworth NL, Zochodne DW, Hahn AF, Pillay N, Chalk C, et al. (2000). Impact of plasma exchange on indices of demyelination in chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve, 23: 206–210.
4. Almeida S, Chalk C, et al. (1999). Isolated trigeminal neuropathy due to trigeminal nerve root hemorrhage. Canadian Journal of Neurological Science, 26: 204–206.
5. Chalk CH (2004). Diseases of the peripheral nervous system. In DC Dale, ed., ACP Medicine, section 11, chap. 2, pp. 1–11.
6. Chalk CH (1997). Acquired peripheral neuropathy. Neurological Clinics, 15: 501–528.
7. Plasma Exchange/Sandoglobulin Guillain-Barré Trial Group (1997). Randomised trail of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome. Lancet, 349(9047): 225–230.

This reviewer reported no financial conflicts.